What is Koelis?
Headquartered in Grenoble, France, with a strategic presence in Princeton and Hong Kong, Koelis specializes in advanced fusion imaging technology designed for precise prostate interventions. The company's flagship platform, Koelis Trinity, integrates 3D ultrasound capabilities with its patented Organ Based Tracking technology. By providing physicians with high-fidelity 3D prostate biopsy cartography, the firm addresses critical gaps in urological diagnostics. With the introduction of the Violette solution, Koelis is expanding its footprint from diagnostic imaging into the focal treatment of prostate cancer, positioning itself as a comprehensive provider in the global Medtech landscape. The company's commitment to innovation is evidenced by its operational reach across more than thirty countries, where it continues to refine surgical precision and patient outcomes.
How much funding has Koelis raised?
Koelis has raised a total of $10.9M across 2 funding rounds:
Debt
$150K
Private Equity
$10.8M
Debt (2020): $150K with participation from PPP
Private Equity (2022): $10.8M led by InnovaHealth Partners
Key Investors in Koelis
InnovaHealth Partners
InnovaHealth Partners is a New York City-based investment firm specializing in growth buyouts of established medical technology companies. The firm focuses on high-growth sectors of the medical device industry, partnering with management teams to develop innovative technologies that address significant unmet surgical needs.
PPP
Public-Private Partnership
What's next for Koelis?
With the support of major enterprise-level funding, Koelis is well-positioned to accelerate its international expansion and deepen its R&D efforts. The strategic focus will likely center on scaling the adoption of the Trinity platform and the commercial rollout of the Violette system. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward capturing a larger share of the global prostate care market. By leveraging its unique intellectual property and established clinical partnerships, Koelis aims to solidify its status as the world leader in fusion imaging, ultimately driving long-term value for stakeholders and improving the standard of care for patients worldwide.
See full Koelis company page
